ketobemidone has been researched along with Neoplasms in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Enig, B | 1 |
Jensen, NH; Jensen, TS; Sjøgren, P | 1 |
Andersen, LS; Kjaer, M; Nielsen, H | 1 |
Borchgrevink, PC; Kaasa, S; Klepstad, P; Skogvoll, E | 1 |
Andersen, LS; Kjaer, M; Nielsen, H; Olsen, FE; Philipsen, J; Velander, G | 1 |
Banning, A; Kaiser, F; Sjøgren, P | 1 |
Kjaer, M; Nielsen, H | 1 |
2 trial(s) available for ketobemidone and Neoplasms
Article | Year |
---|---|
[Sublingual buprenorphine in the treatment of pain caused by cancer. Transition to buprenorphine from other opiates].
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Clinical Trials as Topic; Female; Humans; Male; Meperidine; Middle Aged; Morphinans; Morphine Derivatives; Neoplasms; Pain, Intractable; Palliative Care | 1983 |
[Bioavailability and analgetic effect of sustained-release ketobemidone capsules in patients with chronic pain of cancer].
Topics: Adult; Analgesics, Opioid; Biological Availability; Capsules; Delayed-Action Preparations; Female; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain, Intractable | 1993 |
5 other study(ies) available for ketobemidone and Neoplasms
Article | Year |
---|---|
Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists.
Topics: Adult; Aged; Analgesics, Opioid; Child; Delayed-Action Preparations; Female; Humans; Hyperalgesia; Male; Meperidine; Methadone; Middle Aged; Morphine; Myoclonus; Narcotics; Neoplasms; Pain; Sufentanil | 1994 |
Circadian distribution of oral opioid consumption in cancer patients.
Topics: Adult; Aged; Analgesics, Opioid; Circadian Rhythm; Drug Administration Schedule; Female; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain; Pain Measurement | 2000 |
Bioavailability and analgesic effect of sustained release cetobemidone capsules in cancer patients with chronic pain of malignant origin.
Topics: Adult; Aged; Analgesics, Opioid; Biological Availability; Capsules; Delayed-Action Preparations; Female; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain, Intractable | 1992 |
Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids.
Topics: Acetaminophen; Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Hydromorphone; Male; Meperidine; Middle Aged; Morphine; Morphine Derivatives; Neoplasms; Nicotinic Acids; Pain | 1992 |
Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.
Topics: Administration, Oral; Adult; Aged; Allylamine; Amines; Drug Combinations; Female; Half-Life; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain, Intractable; Tablets | 1988 |